37,537 Shares of Tenet Healthcare Corporation $THC Acquired by Counterpoint Mutual Funds LLC

Key Points

• Counterpoint Mutual Funds LLC acquired 37,537 Tenet Healthcare shares worth approximately $9.6 million, making THC its 25th-largest holding at 0.8% of the portfolio. Institutional investors collectively own 95.44% of the company.
• Tenet reported strong quarterly results, with EPS of $6.12 versus the $4.26 consensus and revenue of $6.04 billion, up 6.8% year over year. The company set fiscal 2026 EPS guidance at $20.30–$21.69, while analysts maintain a “Moderate Buy” consensus and a $278.45 price target.
• Insiders have been selling shares: executives and directors sold 131,199 shares worth about $35.1 million over the past three months. The stock opened at $267.27, near its 52-week high of $283.05, raising valuation concerns despite the positive earnings outlook.

Counterpoint Mutual Funds LLC acquired a new stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 37,537 shares of the company's stock, valued at approximately $9,593,000. Tenet Healthcare makes up about 0.8% of Counterpoint Mutual Funds LLC's portfolio, making the stock its 25th biggest position.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Talon Private Wealth LLC lifted its position in Tenet Healthcare by 35.4% in the 2nd quarter. Talon Private Wealth LLC now owns 23,097 shares of the company's stock valued at $4,321,000 after acquiring an additional 6,044 shares in the last quarter. Hsbc Holdings PLC increased its holdings in shares of Tenet Healthcare by 3,478.7% in the 4th quarter. Hsbc Holdings PLC now owns 266,400 shares of the company's stock worth $53,269,000 after purchasing an additional 258,956 shares in the last quarter. CX Institutional bought a new stake in shares of Tenet Healthcare in the 3rd quarter worth $6,415,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Tenet Healthcare in the second quarter worth $5,504,000. Finally, Louisiana State Employees Retirement System bought a new position in shares of Tenet Healthcare during the first quarter valued at $4,812,000. Hedge funds and other institutional investors own 95.44% of the company's stock.

Insider Transactions at Tenet Healthcare

In other news, EVP Paola Arbour sold 10,878 shares of the firm's stock in a transaction dated Monday, July 27th. The stock was sold at an average price of $243.90, for a total value of $2,653,144.20. Following the transaction, the executive vice president owned 18,413 shares of the company's stock, valued at $4,490,930.70. This trade represents a 37.14% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard Mark sold 10,000 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the transaction, the director directly owned 25,121 shares in the company, valued at $6,617,373.82. This represents a 28.47% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 131,199 shares of company stock valued at $35,065,587. Company insiders own 0.97% of the company's stock.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet raised its 2026 outlook, strengthening the investment case by signaling better-than-expected earnings momentum. The guidance increase could lead to additional estimate revisions and supports the company’s growth narrative. Tenet Healthcare Lifts 2026 Outlook
• Positive Sentiment: Guggenheim raised its price target from $283 to $307 and maintained a Buy rating, implying additional potential upside based on the referenced share price. The target increase reflects greater confidence in Tenet’s earnings outlook. Guggenheim Raises Tenet Healthcare Price Target
• Positive Sentiment: Coverage highlighting Tenet as a long-term growth stock points to its improving fundamentals and potential for continued market outperformance. The guidance raise may further strengthen the bullish case. Why Tenet Healthcare Is a Top Growth Stock
• Neutral Sentiment: Wall Street Zen upgraded Tenet, adding to the generally favorable analyst tone, though the service’s rating change is less significant than the company’s guidance and earnings revisions. Tenet Healthcare Upgraded at Wall Street Zen
• Negative Sentiment: Zacks Research made a modest reduction to its fourth-quarter 2027 EPS estimate, from $5.13 to $5.12, and retains a Hold rating. The small cut is not material but tempers the bullish outlook. Zacks Research Cuts Tenet Healthcare EPS Estimate
• Negative Sentiment: Analysts are questioning whether Tenet’s rally has already priced in the improved outlook. With a forward P/E around 12.5 and shares near their annual high, further gains may require additional earnings upgrades. Tenet Healthcare Valuation Concerns

Tenet Healthcare Trading Down 2.9%

Tenet Healthcare stock opened at $267.27 on Friday. Tenet Healthcare Corporation has a 52-week low of $157.58 and a 52-week high of $283.05. The company has a market cap of $21.52 billion, a P/E ratio of 10.31, a P/E/G ratio of 1.02 and a beta of 1.20. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The business has a 50-day simple moving average of $264.36 and a two-hundred day simple moving average of $219.07.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping the consensus estimate of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.04 billion for the quarter, compared to analysts' expectations of $5.43 billion. During the same quarter last year, the company posted $4.02 EPS. The company's revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Analysts predict that Tenet Healthcare Corporation will post 21.04 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Robert W. Baird lifted their price objective on Tenet Healthcare from $210.00 to $280.00 and gave the stock a "neutral" rating in a report on Tuesday, July 28th. Weiss Ratings upgraded shares of Tenet Healthcare from a "buy (b-)" rating to a "buy (b)" rating in a research note on Thursday, October 8th. Wells Fargo & Company raised their price target on shares of Tenet Healthcare from $231.00 to $281.00 and gave the company an "overweight" rating in a report on Monday, August 3rd. Wall Street Zen upgraded shares of Tenet Healthcare from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Finally, Cantor Fitzgerald reissued an "overweight" rating on shares of Tenet Healthcare in a report on Friday, October 2nd. Eighteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $278.45.

Tenet Healthcare Profile

Tenet Healthcare Corporation is a Dallas-based healthcare services company that operates hospitals, outpatient facilities and other healthcare businesses across the United States. Its operations include acute care hospitals, specialty hospitals, ambulatory surgery centers and related outpatient services.

Through its United Surgical Partners International subsidiary, Tenet is one of the major operators and developers of ambulatory surgery centers in the United States. These facilities provide same-day surgical procedures and other outpatient care across a range of medical specialties.

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.